Homologous recombination (상동재조합, HR) is a type of genetic recombination in which nucleotide sequences are exchanged between two similar or identical molecules of DNA. (https://en.wikipedia.org/wiki/Homologous_recombination)
HR을 통해 DNA의 double strand break repair를 할 수 있는데, BRCA1, BRCA2가 기능을 못하면 이것이 어려워지고, Mutational signature 3 형태의 돌연변이가 많아짐.
Table of Contents
Incoming Links #
Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #
- Biomarkers in triple negative breast cancer: A review
- CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- Mechanisms underlying mutational signatures in human cancers
Related Drug Classes (DrugClass 1) #
Related Articles (Article 2) #
Suggested Pages #
- 0.373 Synthetic lethality
- 0.065 CDK12
- 0.036 Non-homologous end joining
- 0.028 MutaGene
- 0.025
- 0.025 Journal of Clinical Oncology
- 0.025 Base exision repair
- 0.024 Addenbrooke's Hospital
- 0.023 Nucleotide excision repair
- 0.023 Nature Communications
- More suggestions...